A newly published study has described the successful results in mice of a novel vaccine designed to prevent neurodegeneration associated with Alzheimer’s disease. The researchers suggest this “dementia vaccine” is now ready for human trials, and if successful could become the “breakthrough of the next decade.”
New results have been published from one of the first placebo-controlled clinical trials investigating the effects of microdosing Lysergic Acid Diethylamide (LSD). This Phase 1 trial is the first step in testing whether these kinds of psychedelic microdose methods could be useful as a therapeutic approach for treating Alzheimer’s disease, and while the early data doesn’t identify significant cognitive benefits in microdosing, it certainly demonstrates the method is safe enough to proceed to larger efficacy trials.
Theft has been a major issue involved in the ever-growing opioid crisis in America. People are legally prescribed opioid painkillers by their physicians, and find, very often, that they become addicted.
Well, they often can’t return to their doctor for another prescription, so are they forced to hit the streets in search of their next fix. However, the drugs aren’t free, and many who become dependent quickly realize they can’t afford to keep using. But the drug has taken hold and many cannot stop.
So they begin to sell their own possessions – until they run out. Then the now addicts turn to crime – to theft. And many times, the brick and mortar retail store pays the price of that theft.
from Zero Hedge:
“Happening Everywhere In Retail” – Home Depot Links Surge In Thefts To Opioid Crisis
The opioid crisis is evolving and is now becoming a burden on retailers, as addicts race to brick and mortar stores, hoping to steal merchandise, and if successful, sell it on the street or pawn it for cash to pay for their next fix.
Two compelling new studies are building on a hypothesis suggesting age-related dementia is caused by a leaky blood-brain barrier, triggering neuro-inflammation and, ultimately, brain cell damage. The research reveals a novel anti-inflammatory drug can reverse brain aging in senile mice, but experts suggest the studies are interesting but not particularly applicable to human cases of dementia.
from Brent Smith for World Net Daily:
There are some odd things going on in our country lately.
Yes, I know that’s a silly open-ended statement and could refer to just about anything these days. But I’m talking about the seeming disconnect between states and the federal government. Or more specifically, the disconnect between state and federal laws.
In this case, the disconnect between federal marijuana laws and that of the states.
Marijuana is considered an illegal substance by the feds, yet at least 11 states have legalized its purchase and consumption – either strictly medically and/or for recreational use.
The United States Constitution is unmistakably clear concerning the relationship of federal and state law.
Isn’t it funny (not funny ha ha) that our government is the only one who is never to blame for price increases or shortages of any kind. It’s always Big Oil, the military industrial complex, etc. Or in this case, evil Big Pharma. We can’t name one industry that doesn’t get blamed for these occurrences (except of course, Big Education), yet the government, with its penchant for artificially picking winners and losers, escapes all scrutiny. We’re about to see it happen again. And when it has the opposite effect, we’ll all be instructed to once again blame “Big Pharma.”
from Human Events:
“Cold” Medicine: Canadian Drug Imports Will Cost Americans
The solution to drug prices is ending freeriding, not buying Canadian
In the hopes of lowering the cost of prescription drugs for Americans, the Trump Administration announced plans in late July to draft a proposal for the importation and sale of prescription drugs from Canada. The announcement was overshadowed by House Speaker Nancy Pelosi’s drug pricing bill and the bipartisan package before the Senate in September—but is a cause for concern, nonetheless. A dozen states, Congress—even the Trump Administration, despite initial opposition—are now considering such legislation.
If “buy-Canadian” doesn’t sound like a policy consistent with Trump’s platform of putting Americans first, that’s because it isn’t. Importing drugs from Canada is an ineffectual and counterproductive policy. President Trump had it right the first time. The prohibitive drug prices that Americans deal with are not solely caused by pharmaceutical companies; they are primarily the product of a failure of government policy.
Instead of artificial fixes, the Trump Administration should directly address the global freeloading and regulatory glut that’s costing Americans—both in dollars and lives.
The long pursuit of a treatment for peanut allergy is littered with false dawns, but there are also some promising possibilities on the horizon, including one currently on the cusp of FDA approval. Another has just emerged via a promising early trial at Stanford University, where scientists found a single injection of an antibody treatment enabled those with severe allergies to stomach peanuts for some time.
In a stunningly unusual turn of events a new Alzheimer’s drug, previously declared a failure back in March, has been resurrected with the pharmaceutical company behind the treatment suggesting the earlier decision to discontinue the research was premature and based on incorrect data analysis.
Earlier this year we covered a blueberry-sized capsule developed by researchers at MIT that would allow diabetics to take their insulin orally rather than by injection. That capsule contained microneedles to deliver the hormone through the stomach lining. Now, the same team has gone a step further, developing a new capsule that would survive a trip through the stomach and deliver its payload to the lining of the small intestine.